1 |
Allemann IB, Baumann L. 2008. Antioxidants used in skin care formulations. Skin Ther Lett 13:5-9
|
2 |
Aniya Y, Koyama T, Miyagi C, Miyahira M, Inomata C, Kinoshita S, Ichiba T. 2005. Free radical scavenging and hepatoprotective actions of the medicinal herb, Crassocephalum crepidioides from the Okinawa Islands. Biol Pharm Bull 28:19-23
DOI
|
3 |
Baker CL Jr, Ferguson CM. 2005. Future treatment of osteoarthritis. Orthopedics 28:227-234
DOI
|
4 |
Basar S, Uhlenhut K, Hogger P, Schone F, Westendorf J. 2010. Analgesic and antiinflammatory activity of Morinda citrifolia L. (noni) fruit. Phytother Res 24:38-42
DOI
|
5 |
Punjanon T, Nandhasri P. 2005. Analgesic effect of the alcoholic extract from the fruits of Morinda citrifolia. pp.103-106, ISHS Acta Horticulturae 678: III WOCMAP Congress on Medicinal and Aromatic Plants
|
6 |
Davis L, Kuttan G. 2000. Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193-200
DOI
|
7 |
Bostrom CE, Gerde P, Hanberg A, Jernstrom B, Johansson C, Kyrklund T, Rannug A, Tornqvist M, Victorin K, Westerholm R. 2002. Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110:451-488
DOI
|
8 |
Brown AC. 2012. Anticancer activity of Morinda citrifolia (noni) fruit: A review. Phytother Res 26:1427-1440
DOI
|
9 |
Chan-Blanco Y, Vaillant F, Perez AM, Reynes M, Brillouet JM, Brat P. 2006. The noni fruit (Morinda citrifolia L.): A review of agricultural research, nutritional and therapeutic properties. J Food Compos Anal 19:645-654
DOI
|
10 |
Dittmar A. 1993. Morinda citrifolia L.-Use in indigenous Samoan medicine. J Herbs Spices Med Plants 1:77-92
DOI
|
11 |
Dixon AR, McMillen H. Etkin NL. 1999. Ferment this: The transformation of noni, a traditional Polynesian medicine (Morinda citrifolia, Rubiaceae). Econ Bot 53:51-68
DOI
|
12 |
Seifert WF, Bosma A, Hendriks HF, van Leeuwen RE, van Thiel-de Ruiter GC, Seifert-Bock I, Knook DL, Brouwer A. 1995. Beta-carotene (provitamin A) decreases the severity of -induced hepatic inflammation and fibrosis in rats. Liver 15:1-8
DOI
|
13 |
Ramesh S, Radhakrishnan M, Anburaj R, Elangomathavan R, Patharajan S. 2012. Physicochemical, phytochemical and antimicrobial studies on Morinda citrifolia L. fruits at different maturity stages. Int J Pharm Pharm Sci 4:473-476
|
14 |
Rethinam P, Sivaraman K. 2007. Noni (Morinda citrifolia L.) - the miracle fruit: A holistic review. Int J Noni Res 2:4-37
|
15 |
Saludes JP, Garson MJ, Franzblau SG, Aguinaldo AM. 2002. Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn. (Rubiaceae). Phytother Res 16:683-685
DOI
|
16 |
Singh DR. 2012. Morinda citrifolia L. (noni): A review of the scientific validation for its nutritional and therapeutic properties. J Diabetes Endocrinol 3:77-91
DOI
|
17 |
Stocker R, Keaney JF Jr, 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478
DOI
|
18 |
Sunder J, Jeyakumar S, Sujatha T, Kundu A. 2013. Effect of feeding of Morical: A herbal based supplement on production and egg quality in Japanese quails. Adv Anim Vet Sci 1:157-160
|
19 |
Swanholm CE, St John H, Scheuer PJ. 1959. A survey for alkaloids in Hawaiian plants. I. Pac Sci 13:295-305
|
20 |
Tabrah FL, Eveleth BM. 1966. Evaluation of the effectiveness of ancient Hawaiian medicine. Hawaii Med J 25:223-230
|
21 |
Farine JP, Legal L, Moreteau B, Le Quere JL. 1996. Volatile components of ripe fruits of Morinda citrifolia and their effects on Drosophila. Phytochemistry 41:433-438
DOI
|
22 |
Duncan SH, Flint HJ, Stewart CS. 1998. Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites. FEMS Microbiol Lett 164:283-288
DOI
|
23 |
Ettarch RR, Emeka P. 2004. Morinda lucida extract induces endothelium- dependent and -independent relaxation of rat aorta. Fitoterpia 75:332-336
DOI
|
24 |
Farber E. 1984. The multistep nature of cancer development. Cancer Res 44:4217-4223
|
25 |
Furusawa E, Hirazumi A, Story S, Jensen J. 2003. Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) on sarcoma 180 ascites tumour in mice. Phytother Res 17:1158-1164
DOI
|
26 |
Gokce N, Keaney JF Jr, Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh C, Heinecke JW, Vita JA. 1999. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99:3234-3240
DOI
|
27 |
Wang MY, Nowicki D, Anderson G, Jensen J, West B. 2008. Liver protective effects of Morinda citrifolia (noni). Plant Food Hum Nutr 63:59-63
DOI
|
28 |
Vane JR, Botting RM. 1998. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 104:2S-8S
DOI
|
29 |
Wang M, Kikuzaki H, Csiszar K, Boyd CD, Maunakea A, Fong SF, Ghai G, Rosen RT, Nakatani N, Ho CT. 1999. Novel trisaccharide fatty acid ester identified from the fruits of Morinda citrifolia (noni). J Agric Food Chem 47:4880-4882
DOI
|
30 |
Wang MY, Lutfiyya MN, Weidenbacher-Hoper V, Anderson G, Su CX, West BJ. 2009. Antioxidant activity of noni juice in heavy smokers. Chem Cent J 3:13
DOI
|
31 |
Wang MY, Su C. 2001. Cancer preventive effect of Morinda citrifolia (noni). Ann N Y Acad Sci 952:161-168
DOI
|
32 |
Wang MY, West BJ, Jensen CJ, Nowicki D, Su C, Palu A K, Anderson G. 2002. Morinda citrifolia (noni): A literature review and recent advances in noni research. Acta Pharmacol Sin 23:1127-1141
|
33 |
West BJ, Deng S, Palu AK, Jensen CJ. 2009. Morinda citrifolia Linn. (Rubiaceae) leaf extracts mitigate UVB-induced erythema. J Nat Med 63:351-354
DOI
|
34 |
Whistler WA. 1992. Tongan Herbal Medicine. pp.89-90. University of Hawaii Press
|
35 |
Willcox JK, Ash SL, Catignani GL. 2004. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 44:275-295
DOI
|
36 |
Hirazumi A, Furusawa E. 1999. An immunomodulatory polysaccharide-rich substance from the fruit juice of Morinda citrifolia (noni) with antitumour activity. Phytother Res 13:380-387
DOI
|
37 |
Heinicke RM. 1983. Xeronine, a new alkaloid, useful in medical, food and industrial fields. US Patent 4,409,144
|
38 |
Heinicke RM. 1985. The pharmacologically active ingredient of noni. Pac Trop Bot Gard Bull 15:10-14
|
39 |
Higa I, Fuyama Y. 1993. Genetics of food preference in Drosophila sechellia. I. Responses to food attractants. Genetica 88:129-136
DOI
|
40 |
Hornick CA, Myers A, Sadowska-Krowicka H, Anthony CT, Woltering EA. 2003. Inhibition of angiogenic initiation and disruption of newly established human vascular networks by juice from Morinda citrifolia (noni). Angiogenesis 6:143-149
DOI
|
41 |
Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. 2007. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 38:151-156
DOI
|
42 |
Jainkittivong A, Butsarakamruha T, Langlais RP. 2009. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108:394-398
DOI
|
43 |
Joharapurkar AA, Zambad SP, Wanjari MM, Umathe SN. 2003. In vivo evaluation of antioxidant activity of alcoholic extract of Rubia cordifolia Linn. and its influence on ethanol-induced immunosuppression. Indian J Pharmacol 35:232-236
|
44 |
Levand O, Larson HO. 1979. Some chemical constituents of Morinda citrifolia. Planta Med 36:186-187
DOI
|
45 |
Kamiya K, Tanaka Y, Endang H, Umar M, Satake T. 2004. Chemical constituents of Morinda citrifolia fruits inhibit copper-induced low-density lipoprotein oxidation. J Agric Food Chem 52:5843-5848
DOI
|
46 |
Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK, Shin TY. 2006. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 91:123-131
DOI
|
47 |
Legal L, Chappe B, Jallon JM. 1994. Molecular basis of Morinda citrifolia (L.): Toxicity on drosophila. J Chem Ecol 20:1931-1943
DOI
|
48 |
Li RW, Myers SP, Leach DN, Lin GD, Leach G. 2003. A cross-cultural study: Anti-inflammatory activity of Australian and Chinese plants. J Ethnopharmacol 85:25-32
DOI
|
49 |
Locher CP, Burch MT, Mower HF, Berestecky J, Davis H, Van Poel B, Lasure A, Vanden Berghe DA, Vlietinck AJ. 1995. Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 49:23-32
DOI
|
50 |
Liu SL, Degli Esposti S, Yao T, Diehl AM, Zern MA. 1995. Vitamin E therapy of acute -induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 22:1474-1481
DOI
|
51 |
Mathivanan N, Surendiran G, Srinivasan K, Sagadevan E, Malarvizhi K. 2005. Review on the current scenario of noni research: Taxonomy, distribution, chemistry, medicinal and therapeutic values of Morinda citrifolia. Int J Noni Res 1:1-16
|
52 |
McClatchey W. 2002. From Polynesian healers to health food stores: Changing perspectives of Morinda citrifolia (Rubiaceae). Integr Cancer Ther 1:110-120
DOI
|
53 |
Motshakeri M, Ghazali HM. 2015. Nutritional, phytochemical and commercial quality of noni fruit: A multi-beneficial gift from nature. Trends Food Sci Technol 45:118-129
DOI
|
54 |
Mckoy MG, Thomas EA, Simon OR. 2002. Preliminary investigation of the anti-inflammatory properties of an aqueous extract from Morinda citrifolia (noni). Proc West Pharmacol Soc 45:76-78
|
55 |
Mohd Zin Z, Abdul Hamid A, Osman A, Saari N, Misran A. 2007. Isolation and identification of antioxidative compound from fruit of mengkudu (Morinda citrifolia L.). Int J Food Prop 10:363-373
DOI
|
56 |
Morton JF. 1992. The ocean-going noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its "colorful" relatives. Econ Bot 46:241-256
DOI
|
57 |
Nayak BS, Marshall JR, Isitor G, Adogwa A. 2011. Hypoglycemic and hepatoprotective activity of fermented fruit juice of Morinda citrifolia (noni) in diabetic rats. J Evidence-Based Complementary Altern Med p.875293
|
58 |
Nayak S, Mengi S. 2010. Immunostimulant activity of noni (Morinda citrifolia) on T and B lymphocytes. Pharm Biol 48:724-731
DOI
|
59 |
Xue W, Warshawsky D. 2005. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol Appl Pharmacol 206:73-93
DOI
|
60 |
Yang J, Gadi R, Thomson T. 2011. Antioxidant capacity, total phenols, and ascorbic acid content of noni (Morinda citrifolia) fruits and leaves at various stages of maturity. Micronesica 41:167-176
|
61 |
Oh HI, Park HB, Ju MS, Jung SY, Oh MS. 2010. Comparative study of anti-oxidant and anti-inflammatory activities between Curcumae longae radix and Curcumae longae rhizoma. Korea J Herbol 25:83-91
DOI
|
62 |
Ohara Y, Peterson TE, Harrison DG. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551
DOI
|
63 |
Zin ZM, Abdul-Hamid A, Osman A. 2002. Antioxidative activity of extracts from Mengkudu (Morinda citrifolia L.) root, fruit and leaf. Food Chem 78:227-231
DOI
|
64 |
Yoo JS, Hwang JT, Yoo ES, Cheun BS. 2004. Study on herbal extract on the noni (Morinda citriforia). Korean J Biotechnol Bioeng 19:110-112
|
65 |
Yoon JA, Shin KO. 2018. Studies on the biological activity of synbiotics: A review. Korean J Food Nutr 31:319-327
DOI
|
66 |
Younos C, Rolland A, Fleurentin J, Lanhers MC, Misslin R, Mortier F. 1990. Analgesic and behavioural effects of Morinda citrifolia. Planta Med 56:430-443
DOI
|
67 |
Ahmad MS, Sheeba AA, Rai KB. 2012. Cancer preventive effect of Morinda citrifolia (noni) fruit juice against the aflatoxin-B1-induced genotoxicity in human peripheral lymphocytes in vitro. IOSR J Pharm 2:228-234
DOI
|
68 |
Pawlus AD, Kinghorn AD. 2007. Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). J Pharm Pharmacol 59:1587-1609
DOI
|
69 |
Palu AK, Kim AH, West BJ, Deng S, Jensen J, White L. 2008. The effects of Morinda citrifolia L. (noni) on the immune system: Its molecular mechanisms of action. J Ethnopharmacol 115:502-506
DOI
|
70 |
Pande M, Naiker M, Mills G, Singh N, Voro T. 2005. The Kura files: Qualitative social survey. Pac Health Dialog 12:85-93
|
71 |
Peter PI. 2007. Clinical research on Morinda citrifolia L.- noni. Noni Cli Res J 1:4-19
|
72 |
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. 2004. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 3:15-19
|
73 |
Pitot HC, Sirica AE. 1980. The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta (BBA) Rev Cancer 605:191-215
DOI
|
74 |
Prasad V, Jain V, Dorle AK. 2006. Evaluation of Momordica charantia ghrita for immunomodulatory activity. J Plant Sci 1:80-85
DOI
|